Efficacy and Safety of Non-Steroidal Anti-Androgens in Patients with Metastatic Prostate Cancer: Meta-Analysis of Randomized Controlled Trials.

CONCLUSION: Treatment with NSAA was appeared to be better efficacious with respect to PFS, TTD, and response rate with considerable adverse events when compared to the control group in patients with metastatic PCa. PMID: 31692438 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31692438?dopt=Abstract

Source: Reviews on Recent Clinical Trials - November 4, 2019 Category: Cancer & Oncology Authors: Rashid M, Ramesh M, Shamshavali K, Dang A, Patel H, Undela K Tags: Rev Recent Clin Trials Source Type: research